Molly Patterson
Overview
Explore the profile of Molly Patterson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
79
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gales J, McKay R, De Santis L, Rebesco M, Laberg J, Shevenell A, et al.
Nat Commun
. 2023 May;
14(1):2714.
PMID: 37202379
Antarctica's continental margins pose an unknown submarine landslide-generated tsunami risk to Southern Hemisphere populations and infrastructure. Understanding the factors driving slope failure is essential to assessing future geohazards. Here, we...
2.
Patterson M, Caulkett N, Neuhaus P, Pasloske K, Ruckstuhl K
Vet Anaesth Analg
. 2021 May;
48(4):537-540.
PMID: 34023229
Objective: To quantify induction time, reliability, physiological effects, recovery quality and dart volume of a novel formulation of alfaxalone (40 mg mL) used in combination with medetomidine and azaperone for...
3.
Mackintosh N, Agarwal S, Adcock K, Armstrong N, Briley A, Patterson M, et al.
Midwifery
. 2020 Jul;
90:102803.
PMID: 32717660
Objective: Assess the role of online resources and apps for women's help seeking and staff's response to concerns in the perinatal period. Design: Online survey. Descriptive analysis of women's use...
4.
OConnor O, Horwitz S, Hamlin P, Portlock C, Moskowitz C, Sarasohn D, et al.
J Clin Oncol
. 2009 Aug;
27(26):4357-64.
PMID: 19652067
Purpose: To determine the maximum-tolerated dose (MTD) and efficacy of pralatrexate in patients with lymphoma. Patients And Methods: Pralatrexate, initially given at a dose of 135 mg/m(2) on an every-other-week...
5.
Gumbs A, Zain J, Neylon E, MacGregor-Cortelli B, Patterson M, OConnor O
Ann Surg Oncol
. 2009 May;
16(7):2014-7.
PMID: 19408055
Objective: T-cell lymphomas (TCLs) classically have a poorer response to therapy when compared with B-cell lymphomas and account for only 10-15% of all lymphoid malignancies. Hepatosplenic TCLs are a rare...
6.
Marneros A, Grossman M, Silvers D, Husain S, Nuovo G, MacGregor-Cortelli B, et al.
Blood
. 2009 Apr;
113(25):6338-41.
PMID: 19389878
Pralatrexate is a novel antifolate, which shows increased antitumor activity in human tumor xenograft studies in mice compared with methotrexate. We investigated the effects of pralatrexate in a patient with...